Cargando…

Imported Malaria in Travelers Presenting to a Tertiary Urban Hospital, 2000–2016

BACKGROUND: Due to increasing global travel and evolving epidemiologic factors, the number of incident cases of malaria imported into the United States has been growing in recent years. METHODS: We conducted a retrospective review of 90 cases of malaria seen at a single urban university hospital dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Akselrod, Hana, Swierzbinski, Matthew, Parenti, David, Simon, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632220/
http://dx.doi.org/10.1093/ofid/ofx163.160
_version_ 1783269656743641088
author Akselrod, Hana
Swierzbinski, Matthew
Parenti, David
Simon, Gary
author_facet Akselrod, Hana
Swierzbinski, Matthew
Parenti, David
Simon, Gary
author_sort Akselrod, Hana
collection PubMed
description BACKGROUND: Due to increasing global travel and evolving epidemiologic factors, the number of incident cases of malaria imported into the United States has been growing in recent years. METHODS: We conducted a retrospective review of 90 cases of malaria seen at a single urban university hospital during 2000–2016. RESULTS: Of the 90 cases, 77% were Plasmodium falciparum, 14% were either P. ovale or P. vivax, 1% was P. malariae, and the rest were mixed or unknown. Eighty-one patients had traveled to Africa, four to Asia, four to more than one continent, and one to Haiti. Mean age was 41, and 59% were male. The main presenting symptoms were fever (92%), chills (78%), and headache (66%); 10% presented with cerebral malaria. Thirteen cases were managed as outpatients, 59 on a medical ward, and 18 in the ICU. Fourteen (16%) had severe malaria; these were more likely to present with hypotension, non-segmented neutrophilia, hyponatremia, metabolic acidosis, and acute kidney injury (all P < 0.01). Thrombocytopenia was more severe in patients with severe malaria (54,000 vs. 113,000, P < 0.01). Treatment included quinine-based therapy (38%), atovaquone/proguanil (31%), artemether/lumefantrine (19%), and chloroquine/primaquine (11%). Twenty (22%) required change of treatment regimen due to inadequate clinical response or adverse effects. The most common in-hospital complications were ARDS (8%), QT prolongation (7%), and nosocomial infection (4%). Two patients were pregnant at the time of presentation; one suffered severe malaria and fetal loss. Only 3% of patients reported being prescribed a prophylactic regimen and completing it; 20% reported taking an incomplete course, and the majority took no prophylaxis at all. Of 27 patients who had presented to another United States-based medical provider prior to hospitalization, 11 were initially misdiagnosed and treated for conditions other than malaria, including two who underwent extensive hematologic investigations. Inadequate experience and resources in treating malaria were the primary reasons cited for transfer to the tertiary hospital from community-based providers. CONCLUSION: Malaria poses a substantial health risk to US travelers, particularly in light of under-utilization of prophylaxis, lack of familiarity with the disease by local providers, and delays to diagnosis. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5632220
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56322202017-10-12 Imported Malaria in Travelers Presenting to a Tertiary Urban Hospital, 2000–2016 Akselrod, Hana Swierzbinski, Matthew Parenti, David Simon, Gary Open Forum Infect Dis Abstracts BACKGROUND: Due to increasing global travel and evolving epidemiologic factors, the number of incident cases of malaria imported into the United States has been growing in recent years. METHODS: We conducted a retrospective review of 90 cases of malaria seen at a single urban university hospital during 2000–2016. RESULTS: Of the 90 cases, 77% were Plasmodium falciparum, 14% were either P. ovale or P. vivax, 1% was P. malariae, and the rest were mixed or unknown. Eighty-one patients had traveled to Africa, four to Asia, four to more than one continent, and one to Haiti. Mean age was 41, and 59% were male. The main presenting symptoms were fever (92%), chills (78%), and headache (66%); 10% presented with cerebral malaria. Thirteen cases were managed as outpatients, 59 on a medical ward, and 18 in the ICU. Fourteen (16%) had severe malaria; these were more likely to present with hypotension, non-segmented neutrophilia, hyponatremia, metabolic acidosis, and acute kidney injury (all P < 0.01). Thrombocytopenia was more severe in patients with severe malaria (54,000 vs. 113,000, P < 0.01). Treatment included quinine-based therapy (38%), atovaquone/proguanil (31%), artemether/lumefantrine (19%), and chloroquine/primaquine (11%). Twenty (22%) required change of treatment regimen due to inadequate clinical response or adverse effects. The most common in-hospital complications were ARDS (8%), QT prolongation (7%), and nosocomial infection (4%). Two patients were pregnant at the time of presentation; one suffered severe malaria and fetal loss. Only 3% of patients reported being prescribed a prophylactic regimen and completing it; 20% reported taking an incomplete course, and the majority took no prophylaxis at all. Of 27 patients who had presented to another United States-based medical provider prior to hospitalization, 11 were initially misdiagnosed and treated for conditions other than malaria, including two who underwent extensive hematologic investigations. Inadequate experience and resources in treating malaria were the primary reasons cited for transfer to the tertiary hospital from community-based providers. CONCLUSION: Malaria poses a substantial health risk to US travelers, particularly in light of under-utilization of prophylaxis, lack of familiarity with the disease by local providers, and delays to diagnosis. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5632220/ http://dx.doi.org/10.1093/ofid/ofx163.160 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Akselrod, Hana
Swierzbinski, Matthew
Parenti, David
Simon, Gary
Imported Malaria in Travelers Presenting to a Tertiary Urban Hospital, 2000–2016
title Imported Malaria in Travelers Presenting to a Tertiary Urban Hospital, 2000–2016
title_full Imported Malaria in Travelers Presenting to a Tertiary Urban Hospital, 2000–2016
title_fullStr Imported Malaria in Travelers Presenting to a Tertiary Urban Hospital, 2000–2016
title_full_unstemmed Imported Malaria in Travelers Presenting to a Tertiary Urban Hospital, 2000–2016
title_short Imported Malaria in Travelers Presenting to a Tertiary Urban Hospital, 2000–2016
title_sort imported malaria in travelers presenting to a tertiary urban hospital, 2000–2016
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632220/
http://dx.doi.org/10.1093/ofid/ofx163.160
work_keys_str_mv AT akselrodhana importedmalariaintravelerspresentingtoatertiaryurbanhospital20002016
AT swierzbinskimatthew importedmalariaintravelerspresentingtoatertiaryurbanhospital20002016
AT parentidavid importedmalariaintravelerspresentingtoatertiaryurbanhospital20002016
AT simongary importedmalariaintravelerspresentingtoatertiaryurbanhospital20002016